Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132530) titled 'A prospective study on the treatment of severe patients with NTIS by thyroid hormone supplementation therapy' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Northern Jiangsu People's Hospital
Condition:
non-thyroidal illness syndrome
Intervention:
Control group:Only standardized treatment, no special intervention
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2025-09-12
Target Sample Size: Control group:100;Experimental Group:100;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297339
...